Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00668954 · ClinicalTrials.gov registry record · NA

Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus

A NA study of Type 2 Diabetes Mellitus, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT00668954 is a NA study of Type 2 Diabetes Mellitus that has completed, run by University of Colorado, Denver. The registered enrollment target is 26 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00668954, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This is a research study designed to look at how pomegranate juice (or a placebo juice) affects the body through the measurement of specific biomarkers, which are indicators of health.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Pomegranate Juice
  • DIETARY_SUPPLEMENT Placebo Juice

Study Locations (1)

Colorado

  • University of Colorado Denver Center for Human Nutrition - Denver

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2008-04
Est. Completion 2010-11
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT00668954

The ClinicalTrials.gov registry entry for NCT00668954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Pomegranate Juice is the first listed.

NCT00668954 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00668954 about?

NCT00668954 is a clinical study titled "Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus". This is a research study designed to look at how pomegranate juice (or a placebo juice) affects the body through the measurement of specific biomarkers, which are indicators of health.

What is the current status of trial NCT00668954?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2008-04. Estimated completion is 2010-11.

What conditions does trial NCT00668954 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00668954?

The interventions under investigation include: Pomegranate Juice (DIETARY_SUPPLEMENT), Placebo Juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00668954?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00668954 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.